Nicoccino

SVENSKA
  • Home
  • About Nicoccino
    • About Nicoccino
    • Vision, mission and Strategy
    • Business idea and Business model
    • A few words from the CEO
    • Market
    • History
    • Group Structure
    • Board of Directors
    • Management
  • Product & IP
    • Patented and innovative nicotine product
    • Patents and Intellectual Property Right
    • Production and Product Development
    • Sales
  • Investors
    • Financial reports
    • Share Information
    • Risk Factors
    • Accountant
    • Articles of Association
    • Certified adviser
    • Important Information about First North
    • Company Description
    • Presentations
    • Authorization
  • Press
    • Press releases
    • Subscribe
    • Calendar
    • Press images
    • Nicoccino in the press
  • Contact
  • Home
  • About Nicoccino
    • About Nicoccino
    • Vision, mission and Strategy
    • Business idea and Business model
    • A few words from the CEO
    • Market
    • History
    • Group Structure
    • Board of Directors
    • Management
  • Product & IP
    • Patented and innovative nicotine product
    • Patents and Intellectual Property Right
    • Production and Product Development
    • Sales
  • Investors
    • Financial reports
    • Share Information
      • Share Capital
      • Incentive Schemes
      • Largest shareholders
    • Risk Factors
    • Accountant
    • Articles of Association
    • Certified adviser
    • Important Information about First North
    • Company Description
    • Presentations
    • Authorization
  • Press
    • Press releases
    • Subscribe
    • Calendar
    • Press images
    • Nicoccino in the press
  • Contact
  • About Nicoccino
  • Vision, mission and Strategy
  • Business idea and Business model
  • A few words from the CEO
  • Market
  • History
  • Group Structure
  • Board of Directors
  • Management

Vision, Mission and Strategy

VISION

 

To offer a unique and attractive nicotine product that is the most effective on the market. 

 

MISSION 

 

Offer consumers an effective aid to quit smoking. 

 

 

STRATEGIC GOALS

 

  1. Secure a new pharmaceutical manufacturer.
  2. Carry out test, validation and clinical production.
  3. Completion of a clinical study.
  4. Receive a pharmaceutical approval from the Medical Products Agency [MPA].

 

 

TIMELINE

 

WEBSHOPhttp://www.purenicoccino.com
  • About
    • Vision, Mission and Strategy
    • Market
    • Board
    • Management
  • Nicoccino product & IP
    • Patented and innovative nicotine
    • Patents and IP
  • Investors
    • Financial reports
    • Share information
  • Press

CONTACT

 

NICOCCINO HOLDING AB

Lahällsvägen 48

183 30 Täby, Sweden

Email: info@nicoccino.se

Cookies